CRISPR as a driving force: the Model T of biotechnology
- 1k Downloads
The CRISPR system for gene editing can break, repair, and replace targeted sections of DNA. Although CRISPR gene editing has important therapeutic potential, it raises several ethical concerns. Some bioethicists worry CRISPR is a prelude to a dystopian future, while others maintain it should not be feared because it is analogous to past biotechnologies. In the scientific literature, CRISPR is often discussed as a revolutionary technology. In this paper we unpack the framing of CRISPR as a revolutionary technology and contrast it with framing it as a value-threatening biotechnology or business-as-usual. By drawing on a comparison between CRISPR and the Ford Model T, we argue CRISPR is revolutionary as a product, process, and as a force for social change. This characterization of CRISPR offers important conceptual clarity to the existing debates surrounding CRISPR. In particular, conceptualizing CRISPR as a revolutionary technology structures regulatory goals with respect to this new technology. Revolutionary technologies have characteristic patterns of implementation, entrenchment, and social impact. As such, early identification of technologies as revolutionary may help construct more nuanced and effective ethical frameworks for public policy.
KeywordsBiotechnology CRISPR CRISPR/Cas9 Gene editing Gene therapy Revolutionary technology
Funding in support of this research was provided by the Canada Research Chair in Bioethics and Philosophy on “Impact Ethics: Making a Difference” and the Natural Sciences and Engineering Research Council of Canada grant no. GLDSU/447989. We thank the team at Novel Tech Ethics, Dalhousie University for their feedback on earlier drafts.
- Baltimore, D., F. Baylis, P. Berg, G.Q. Daley, J.A. Doudna, E.S. Lander, R. Lovell-Badge, P. Ossorio, D. Pei, A. Thrasher, E. Winnacker, and Q. Zhou. 2015a. On human gene editing: International summit statement. http://www8.nationalacademies.org/onpinews/newsitem.aspx?RecordID=12032015a (Press Release).
- Baltimore, D., P. Berg, M. Botchan, D. Carroll, R.A. Charo, G. Church, J.E. Corn, G.Q. Daley, J.A. Doudna, M. Fenner, H.T. Greely, M. Jinek, S.G. Martin, E. Perhoet, J. Puck, S.H. Sternberg, J.S. Weissman, and K.R. Yamamoto. 2015b. A prudent path forward for genomic engineering and germline gene modification. Science 348(6230): 36–38.CrossRefGoogle Scholar
- Christenson, C. 1997. The innovator’s dilemma. Cambridge, MA: Harvard Business School Press.Google Scholar
- Chung, E. 2015. Synbiota biohacking kits let you do genetic engineering at home. CBC News, October 15. http://www.cbc.ca/news/technology/biohacking-diy-bio-1.3252735. Retrieved November 4, 2015.
- Collingridge, D. 1980. The social control of technology. London: Pinter.Google Scholar
- Cowan, C. 2015. Measuring off-target events, efficiency, and utility. Presentation, information-gathering meeting for the planning committee organizing the international summit on human gene editing, October 5, Washington, DC.Google Scholar
- Dhar, D., and J. Hsi-en Ho. 2009. Stem cell research policies around the world. The Yale Journal of Biology and Medicine 82(3): 113–115.Google Scholar
- Duncan, J. 2011. Any colour-so long as it’s black: Designing the Model T Ford 1906–1908. New Zealand: Exisle Publishing.Google Scholar
- Gantz, V.M., N. Jasinskiene, O. Tatarenkova, A. Fazekas, V.A. Macias, E. Bier, and A.A. James. 2015. November 23). Highly efficient Cas9-mediated gene drive for population modification of the malaria vector mosquito Anopheles stephensi. Proceedings of the National Academy of Sciences 112(49): E6736–E6743.CrossRefGoogle Scholar
- Hosman, E. 2015. Gene therapy: Comeback? Cost-prohibitive? Biopoliticaltimes.org, November 19. http://www.biopoliticaltimes.org/article.php?id=8991. Retrieved November 20, 2015.
- Ingrassia, P. 2008. This car changed America: A look at Ford’s Model T, which debuted 100 years ago. Wall Street Journal, September 27. http://www.wsj.com/articles/SB122246777029780525. Retrieved November 24, 2015.
- Kutter, S. 2015. Gene therapy conquered: The 1-million-euro syringe. Wirtschafts Woche Medicine, April 4. http://www.wiwo.de/technologie/forschung/gen-therapie-erobert-deutschland-die-1-million-euro-spritze/11499176-all.html. Retrieved November 4, 2015.
- Larson, C. 2015. China’s bold push into genetically customized animals. Science American, November 17. http://www.scientificamerican.com/article/china-s-bold-push-into-genetically-customized-animals/. Retrieved November 20, 2015.
- Lewis, T. 2015. Chinese scientists want to sell these teensy genetically-engineered pigs as pets. Business Insider, September 30. http://www.businessinsider.com/chinese-genetically-engineered-mini-pigs-2015-9. Retrieved November 4, 2015.
- Li, F.D., Y. Li, H. Liu, H.H. Zhang, C.X. Liu, X.J. Zhang, H.W. Dou, W.X. Yang, and Y.T. Du. 2014. Production of GHR double-allelic knockout Bama pig by TALENs and handmade cloning. Yi Chuan 36(9): 903–911.Google Scholar
- Mariscal, C. 2015. Universal biology: Assessing universality from a single example. In The impact of discovering life beyond earth, ed. S. Dick. Cambridge: Cambridge University Press.Google Scholar
- Reardon, S. 2015. Leukaemia success heralds wave of gene-editing therapies. Nature News 527(7577): 146–147. http://www.nature.com/news/leukaemia-success-heralds-wave-of-gene-editing-therapies-1.18737. Retrieved November 5, 2015.
- Sander, J.D., E.J. Dahlborg, M.J. Goodwin, L. Cade, F. Zhang, D. Cifuentes, S.J. Curtin, S.J. Blackburn, S. Thibodeau-Beganny, Y. Qi, C.J. Pierick, E. Hoffman, M.L. Maeder, C. Khayter, D. Reyon, D. Dobbs, D.M. Langenau, R.M. Stupar, A.J. Giraldez, D.F. Voytas, R.T. Peterson, J.R.J. Yeh, and J.K. Joung. 2011. Selection-free zinc-finger-nuclease engineering by context-dependent assembly (CoDA). Nature Methods 8(1): 67–69.CrossRefGoogle Scholar
- Sigma-Aldrich. 2011. Sigma® life science reaches milestone in gene editing with increased affordability for CompoZr® ZFNs and the expansion of knockout ZFNs to include every gene in mice and rats advances in technology platform and new production center result in more content and less expensive Compozr ZFNs. http://investor.sigmaaldrich.com/releasedetail.cfm?ReleaseID=596302. Retrieved November 4, 2015.
- Specter, M. 2015. The gene hackers. The New Yorker, November 16. http://www.newyorker.com/magazine/2015/11/16/the-gene-hackers. Retrieved November 20, 2015.
- Sturgeon, T., and Florida, R. (2000). Globalization and jobs in the automotive industry. Final report to the Alfred P. Sloan Foundation. International Motor Vehicle Program, Center for Technology, Policy, and Industrial Development, Massachusetts Institute of Technology. https://www.creativeclass.com/rfcgdb/articles/2000-The_World_That_Changed_The_Machine_Globalization_And_Jobs_In_The_Automotive_Industry.pdf. Retrieved November 5, 2015.
- U.S. Food and Drug Administration (FDA). 2015. Cellular and gene therapy products, October 20. http://www.fda.gov/biologicsbloodvaccines/cellulargenetherapyproducts/default.htm. Retrieved November 4, 2015.
- Womack, J.P., D.T. Jones, and D. Roos. 1990. The machine that changed the world. New York: Rawson Associates.Google Scholar
- Yeadon, J. 2015. Pros and cons of ZFNs, TALENs, and CRISPR/Cas. https://www.jax.org/news-and-insights/jax-blog/2014/march/pros-and-cons-of-znfs-talens-and-crispr-cas. Retrieved November 4, 2015.
- Zhou, Q. 2015. Overview of Chinese gene editing research and policy. Question and answer period, information-gathering meeting for the planning committee organizing the international summit on human gene editing, October 5, Washington, DC.Google Scholar
- Zimmer, C. 2013. Bringing them back to life. National Geographic 223(4): 28.Google Scholar